Carregant...
Therapeutic monoclonal antibodies and the need for targeted pharmacovigilance in India
A growing number of innovative mAb therapeutics are on the global market, and biosimilar versions have now also been approved, including in India. Although efficacy and safety is demonstrated prior to approval, targeted pharmacovigilance is essential for the identification and assessment of risk for...
Guardat en:
| Publicat a: | MAbs |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4623424/ https://ncbi.nlm.nih.gov/pubmed/25523367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/19420862.2014.985547 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|